Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping
Giulio Sozzi(University of Palermo), Vito Chiàntera(University of Palermo), Giorgia Monterossi(Agostino Gemelli University Polyclinic), Francesco Fanfani(Agostino Gemelli University Polyclinic), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vincenzo Giallombardo(University of Palermo), Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Ilaria Capasso(Università Cattolica del Sacro Cuore), Giorgia Dinoi(Agostino Gemelli University Polyclinic), Mariano Catello Di Donna(University of Palermo), Stefano Restaino(University of Udine), Natalina Buono(University of Palermo), Stefano Uccella(University of Insubria)
Cited by 63
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299